115 related articles for article (PubMed ID: 11322381)
1. Glypicans and the biology of renal malformations.
Grisaru S; Rosenblum ND
Pediatr Nephrol; 2001 Mar; 16(3):302-6. PubMed ID: 11322381
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
Veugelers M; Cat BD; Muyldermans SY; Reekmans G; Delande N; Frints S; Legius E; Fryns JP; Schrander-Stumpel C; Weidle B; Magdalena N; David G
Hum Mol Genet; 2000 May; 9(9):1321-8. PubMed ID: 10814714
[TBL] [Abstract][Full Text] [Related]
3. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis.
Grisaru S; Cano-Gauci D; Tee J; Filmus J; Rosenblum ND
Dev Biol; 2001 Mar; 231(1):31-46. PubMed ID: 11180950
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
Cano-Gauci DF; Song HH; Yang H; McKerlie C; Choo B; Shi W; Pullano R; Piscione TD; Grisaru S; Soon S; Sedlackova L; Tanswell AK; Mak TW; Yeger H; Lockwood GA; Rosenblum ND; Filmus J
J Cell Biol; 1999 Jul; 146(1):255-64. PubMed ID: 10402475
[TBL] [Abstract][Full Text] [Related]
5. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome.
Li M; Shuman C; Fei YL; Cutiongco E; Bender HA; Stevens C; Wilkins-Haug L; Day-Salvatore D; Yong SL; Geraghty MT; Squire J; Weksberg R
Am J Med Genet; 2001 Aug; 102(2):161-8. PubMed ID: 11477610
[TBL] [Abstract][Full Text] [Related]
6. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
7. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition.
DeBaun MR; Ess J; Saunders S
Mol Genet Metab; 2001 Apr; 72(4):279-86. PubMed ID: 11286501
[TBL] [Abstract][Full Text] [Related]
8. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.
Gonzalez AD; Kaya M; Shi W; Song H; Testa JR; Penn LZ; Filmus J
J Cell Biol; 1998 Jun; 141(6):1407-14. PubMed ID: 9628896
[TBL] [Abstract][Full Text] [Related]
9. glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development.
Paine-Saunders S; Viviano BL; Zupicich J; Skarnes WC; Saunders S
Dev Biol; 2000 Sep; 225(1):179-87. PubMed ID: 10964473
[TBL] [Abstract][Full Text] [Related]
10. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A
Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487
[TBL] [Abstract][Full Text] [Related]
11. Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest.
Farooq M; Hwang SY; Park MK; Kim JC; Kim MK; Sung YK
Mol Cells; 2003 Jun; 15(3):356-60. PubMed ID: 12872992
[TBL] [Abstract][Full Text] [Related]
12. Glypican 3 and glypican 4 are juxtaposed in Xq26.1.
Huber R; Mazzarella R; Chen CN; Chen E; Ireland M; Lindsay S; Pilia G; Crisponi L
Gene; 1998 Dec; 225(1-2):9-16. PubMed ID: 9931407
[TBL] [Abstract][Full Text] [Related]
13. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
Xuan JY; Hughes-Benzie RM; MacKenzie AE
J Med Genet; 1999 Jan; 36(1):57-8. PubMed ID: 9950367
[TBL] [Abstract][Full Text] [Related]
14. Glypicans in growth control and cancer.
Filmus J
Glycobiology; 2001 Mar; 11(3):19R-23R. PubMed ID: 11320054
[TBL] [Abstract][Full Text] [Related]
15. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13.
Paine-Saunders S; Viviano BL; Saunders S
Genomics; 1999 May; 57(3):455-8. PubMed ID: 10329016
[TBL] [Abstract][Full Text] [Related]
16. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
Hartwig S; Hu MC; Cella C; Piscione T; Filmus J; Rosenblum ND
Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
[TBL] [Abstract][Full Text] [Related]
17. A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome.
Okamoto N; Yagi M; Imura K; Wada Y
J Hum Genet; 1999; 44(5):327-9. PubMed ID: 10496077
[TBL] [Abstract][Full Text] [Related]
18. The loss of glypican-3 induces alterations in Wnt signaling.
Song HH; Shi W; Xiang YY; Filmus J
J Biol Chem; 2005 Jan; 280(3):2116-25. PubMed ID: 15537637
[TBL] [Abstract][Full Text] [Related]
19. Genotype/phenotype correlations of males affected by Simpson-Golabi-Behmel syndrome with GPC3 gene mutations: patient report and review of the literature.
Mariani S; Iughetti L; Bertorelli R; Coviello D; Pellegrini M; Forabosco A; Bernasconi S
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):225-32. PubMed ID: 12713262
[TBL] [Abstract][Full Text] [Related]
20. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D
Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]